JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

J Cell Sci. 2002 Nov 15;115(Pt 22):4317-25. doi: 10.1242/jcs.00082.

Abstract

Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNK1, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes (BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (JunAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-Jun-phosphorylation-dependent and -independent mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Binding Sites / drug effects
  • Binding Sites / genetics
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / enzymology*
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology*
  • Cells, Cultured
  • Glycoproteins / metabolism
  • Glycoproteins / pharmacology
  • Mice
  • Mice, Knockout
  • Mitogen-Activated Protein Kinase 8
  • Mitogen-Activated Protein Kinase 9
  • Mitogen-Activated Protein Kinases / deficiency*
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / genetics
  • Monocytes / drug effects
  • Monocytes / enzymology*
  • Mutation / genetics
  • Myeloid Progenitor Cells / drug effects
  • Myeloid Progenitor Cells / enzymology*
  • Osteoclasts / drug effects
  • Osteoclasts / enzymology*
  • Osteoprotegerin
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-jun / deficiency*
  • Proto-Oncogene Proteins c-jun / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Tumor Necrosis Factor
  • Transcription Factor AP-1 / drug effects
  • Transcription Factor AP-1 / metabolism

Substances

  • Glycoproteins
  • Osteoprotegerin
  • Proto-Oncogene Proteins c-jun
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • Tnfrsf11b protein, mouse
  • Transcription Factor AP-1
  • Mitogen-Activated Protein Kinase 9
  • Mitogen-Activated Protein Kinase 8
  • Mitogen-Activated Protein Kinases